The 4th General Assembly Meeting took place virtually on o4. June 2024.
The finalisation of the clinical study design and related proposals for ethics approvals are in preparation. The study will validate the professional dashboard that includes the visualisation of the diagnosis and prognosis algorithms that is currently in its integration phase.
Interviews with stakeholders as input for business and marketing strategies to support the commercialisation will start soon.